[The study of a key molecule Caspase-1 of inflammasome in hepatitis B virus-related diseases]

Z H Fan1, L Xu1, Y Tian1

  • 1Beijing Youan Hospital, Capital Medical University & Beijing Institute of Hepatology, Beijing 100069, China.

Insights

Aspartate-specific cysteine protease (Caspase)-1 plays a key role in hepatitis B virus (HBV)-related liver diseases. Its expression and activity differ significantly across conditions like chronic hepatitis B, cirrhosis, hepatocellular carcinoma, and acute-on-chronic liver failure.

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Context:

  • Hepatitis B virus (HBV) infection is a global health concern, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma.
  • Inflammasomes, particularly involving Caspase-1, are implicated in inflammatory responses and disease pathogenesis.
  • Understanding the role of Caspase-1 in HBV-related liver conditions is crucial for developing targeted therapies.

Purpose:

  • To investigate the expression, activity, and role of aspartate-specific cysteine protease (Caspase)-1 in various hepatitis B virus (HBV)-related liver diseases.
  • To compare Caspase-1 levels and activity in patients with chronic hepatitis B (CHB), liver cirrhosis (LC), hepatocellular carcinoma (HCC), and acute-on-chronic liver failure (ACLF) against healthy controls.

Summary:

  • Real-time PCR revealed altered Caspase-1 mRNA levels in CHB, LC, HCC (downregulated), and ACLF (upregulated) patients compared to controls.
  • Immunofluorescence showed varied Caspase-1 protein levels, with elevation in ACLF and reduction in HCC and LC.
  • Caspase-1 activity was slightly increased in CHB, LC, and HCC tissues but significantly reduced in ACLF. Serum Caspase-1 levels were universally lower in HBV patients, with the lowest levels observed in ACLF.

Impact:

  • Caspase-1 exhibits distinct expression patterns and activity profiles in different HBV-related liver diseases, particularly highlighting its unique role in ACLF.
  • These findings suggest Caspase-1 as a potential biomarker for disease severity and progression in HBV infection.
  • The study provides insights into the inflammatory mechanisms underlying HBV pathogenesis, paving the way for novel therapeutic strategies targeting inflammasomes.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.7K